Performance Management is Key to Business Ethics
Patrik Florencio & David Clark discuss the critical role of performance management in building a culture of integrity and ethics.
Business Law Practice
10-Q&A Episode 15: A Lifetime of Lessons in Law and Business – An Interview with Randy Kominsky
Randy Kominsky (LAW ’79) shares why clerkships are invaluable to transactional attorneys, what it was like navigating one of the largest airline bankruptcies in history, and how every young professional can improve their odds for success. Interviewer: Nate Trager (LAW ’22; MBA ’22) Guests: Randy Kominsky
Ceres Guidance for Engaging on Climate Risk Governance and Voting on Directors
Katayun Jaffari discusses guidance issued by Ceres on solving climate and sustainability challenges, the potential implications of this guidance, and how it should be considered and implemented by companies.
DOJ Continues Crackdown on No-Poach Agreements
Nathan J. Larkin (LAW ’20) of Cozen O’Connor co-authored an article with Stephen A. Miller discussing the DOJ’s market collusion crackdown of no-poach and wage-fixing agreements between competitors, as showcased in United States v. DaVita Inc.
‘Country Road, Take Me . . . Where?’ New “Deconstruction of the Administrative State” Decision – What is a Business Law Practitioner to do?
Professor Jonathan Broder assesses the impact of the recent SCOTUS decision against the Environmental Protection Agency on the power of administrative agencies over regulated industries.
Novel Certification Requirement by Chief Compliance Officers Not Always a Bad Thing
Professor Donnella pushes back against criticism of the recent DOJ sanction of Glencore International.
Defense Bar Commentary Highlights Practice Points for Biotech Securities Litigation
A panel of corporate advisors updated their 2017 survey of securities litigation involving development-stage biotech companies, providing important practice points for the institutional investor and concluding that biotech start-ups do not pose a greater securities class action risk compared to other companies. Stronger cases involved plaintiffs making credible allegations that defendants intentionally misrepresented data or facts about their interactions with the FDA, omitted adverse regulator feedback, or presented misleading information about regulatory milestones or assessments.
LeClairRyan Bankruptcy Highlights Pass-Through Tax Issue
Hannah Travaglini (LAW ’21) of Montgomery McCracken co-authored an article with Edward Schnitzer discussing the recent court decision in the LeClairRyan bankruptcy and, more broadly, the tax ramifications of different corporate entity structures during bankruptcy.
Vertical Forum Shopping in Bankruptcy
Professor Jonathan Lipson discusses the emerging issue of vertical forum shopping in chapter 11 bankruptcy cases.
Is Government Better at Corporate Reform Than Corporations?
Professor Donnella discusses the role of corporations in reforming their internal compliance and ethical guidelines